Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Exercise) trial
- 31 January 2003
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 145 (1) , 179-186
- https://doi.org/10.1067/mhj.2003.39
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: